Therapeutic application of alpha-1-antitrypsin in COVID-19
Felix Ritzmann, Praneeth Chitirala, Yiwen Yao, Nadine Krüger, Markus Hoffmann, Wei Zuo, Frank Lammert, Sigrun Smola, Nastasja Seiwert, Naveh Tov, Noga Alagem, Bahareh Mozafari, Katharina Günther, Martina Seibert, Sabrina Hörsch, Thomas Volk, Philipp M. Lepper, Guy Danziger, Stefan Pöhlmann, Christoph Beisswenger, View ORCID ProfileChristian Herr, Robert Bals
doi: https://doi.org/10.1101/2021.04.02.21252580
Felix Ritzmann
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Praneeth Chitirala
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Yiwen Yao
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Nadine Krüger
2Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, D-37077 Göttingen, Germany
Markus Hoffmann
2Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, D-37077 Göttingen, Germany
3Faculty of Biology and Psychology, University Göttingen, 37073 Göttingen, Germany
Wei Zuo
4Shanghai East Hospital, School of Medicine, Tongji University, 200433 Shanghai, China
Frank Lammert
5Department of Internal Medicine II, Saarland University Medical Center, Saarland University, D-66421, Germany
Sigrun Smola
6Institute of Virology, Saarland University Medical Center, D-66421 Homburg, Germany
Nastasja Seiwert
6Institute of Virology, Saarland University Medical Center, D-66421 Homburg, Germany
Naveh Tov
7Kamada Ltd, Rehovot, 7670402 Israel
Noga Alagem
7Kamada Ltd, Rehovot, 7670402 Israel
Bahareh Mozafari
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Katharina Günther
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Martina Seibert
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Sabrina Hörsch
8Department of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Faculty of Medicine, Saarland University, Homburg, Germany
Thomas Volk
8Department of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Faculty of Medicine, Saarland University, Homburg, Germany
Philipp M. Lepper
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Guy Danziger
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Stefan Pöhlmann
2Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, D-37077 Göttingen, Germany
3Faculty of Biology and Psychology, University Göttingen, 37073 Göttingen, Germany
Christoph Beisswenger
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Christian Herr
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Robert Bals
1Department of Internal Medicine V – Pulmonology, Allergology and Critical Care Medicine, Saarland University, D-66421 Homburg, Germany
Article usage
Posted April 06, 2021.
Therapeutic application of alpha-1-antitrypsin in COVID-19
Felix Ritzmann, Praneeth Chitirala, Yiwen Yao, Nadine Krüger, Markus Hoffmann, Wei Zuo, Frank Lammert, Sigrun Smola, Nastasja Seiwert, Naveh Tov, Noga Alagem, Bahareh Mozafari, Katharina Günther, Martina Seibert, Sabrina Hörsch, Thomas Volk, Philipp M. Lepper, Guy Danziger, Stefan Pöhlmann, Christoph Beisswenger, Christian Herr, Robert Bals
medRxiv 2021.04.02.21252580; doi: https://doi.org/10.1101/2021.04.02.21252580
Therapeutic application of alpha-1-antitrypsin in COVID-19
Felix Ritzmann, Praneeth Chitirala, Yiwen Yao, Nadine Krüger, Markus Hoffmann, Wei Zuo, Frank Lammert, Sigrun Smola, Nastasja Seiwert, Naveh Tov, Noga Alagem, Bahareh Mozafari, Katharina Günther, Martina Seibert, Sabrina Hörsch, Thomas Volk, Philipp M. Lepper, Guy Danziger, Stefan Pöhlmann, Christoph Beisswenger, Christian Herr, Robert Bals
medRxiv 2021.04.02.21252580; doi: https://doi.org/10.1101/2021.04.02.21252580
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2805)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12484)
- Forensic Medicine (10)
- Gastroenterology (793)
- Genetic and Genomic Medicine (4355)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2804)
- Health Policy (1040)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (457)
- Neurology (4119)
- Nursing (219)
- Nutrition (611)
- Oncology (2177)
- Ophthalmology (614)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1165)
- Primary Care Research (478)
- Public and Global Health (6714)
- Radiology and Imaging (1472)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (358)
- Surgery (467)
- Toxicology (57)
- Transplantation (196)
- Urology (173)